After encouraging results on a vaginal gel containing the antiretroviral drug tenofovir, which reduces HIV infection and risk of contracting genital herpes, a follow-up study to test the safety of the gel has been launched. Editors Notes: It now looks like women who bed condom averse men (so called members of the human race - sies, ga, ptooie!) will now at least have a better than zero chance of contracting HIV or herpes. The Phase III trial, to be known as FACTS 001, will be conducted by … [Read more...] about HIV Gel Reduces Infection by 39%

